Scientists test 'Cancer-Killing Virus' for Tough-to-Treat lung cancer
NCT ID NCT06125197
Summary
This early-stage trial is testing the safety of a new two-part treatment for advanced non-small cell lung cancer. The treatment combines a modified virus designed to attack tumors with an existing immunotherapy drug. It is for patients whose cancer has continued to grow despite previous immunotherapy treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hoag Memorial Hospital Presbyterian
Newport Beach, California, 92658, United States
-
UCLA Jonsson Comprehensive Cancer Center
Santa Monica, California, 90404, United States
Conditions
Explore the condition pages connected to this study.